Macular Degeneration and Treatment

Mine Ün, Sedef Öztürk

DOI: 10.5606/jebms.2020.75600

Issue: 2020, Volume 1 - Issue 1
1347 1351

Migraine and Calcitonin Gene-Related Peptide Receptor Antagonist Treatment

Yasemin Akbaş

DOI: 10.5606/jebms.2020.75617

Issue: 2020, Volume 1 - Issue 2
1209 1170

Familial Autism Genes

Ezgi Seda Yayla

DOI: 10.5606/jebms.2020.75621

Issue: 2020, Volume 1 - Issue 3
1381 1234

What Does CRISPR Technology Provide to Cancer Treatments?

Güner Yaman, Nilsu Çini, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75637

Issue: 2021, Volume 2 - Issue 1
1723 954

Multiple Myeloma Treatment

Edanur Tekin, Özge Çağlar, Elif Özyılmaz, Oytun Erbaş

DOI: 10.5606/jebms.2021.75658

Issue: 2021, Volume 2 - Issue 2
856 731

Metformin as Cancer Preventative and Therapeutic Agent

İlayda Üzümcü, Burak Akverdi, Elif Ünaldı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1006

Issue: 2022, Volume 3 - Issue 1
1205 705

Depression and Cardiovascular Disease: A Mutual Relationship

Bahar Işık,Oytun Erbaş

DOI: 10.5606/jebms.2023.1041

Issue: 2023, Volume 4 - Issue 1
739 717

Emerging Immunotherapeutic Approaches for Managing Metastasis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2023.1050

Issue: 2023, Volume 4 - Issue 2
768 608

Revolutionizing Health Technologies: The Transformative Power of Stem Cells

Tutku Özaydın, Kerem Can Tunç, Oytun Erbaş

DOI: 10.5606/jebms.2024.1071

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
712 467

Stem Cell Applications: A Promising Future for Autoimmune Diseases?

Öznur Safgöl, Oytun Erbaş

DOI: 10.5606/jebms.2024.1075

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
556 509

Stem Cells in Surgery

Buse Kaptan, Oytun Erbaş

DOI: 10.5606/jebms.2024.1080

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
558 407

Cancer Stem Cells

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1083

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
690 484

Histone Deacetylase Inhibitors in Cancer Treatment

Şule Demirkasaoğlu, Oytun Erbaş

DOI: 10.5606/jebms.2024.1102

Issue: 2024, Volume 5 - Issue 4
284 281